Metraipolis › archive › dc_a3bb1571b4fb

Glycocalyx-targeted therapy prevents age-related muscle loss and declines in maximal exercise capacity — Europe PMC PMID:40892009

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40892009
DOI
10.18632/aging.206313
License (as archived)
solo-consultazione
Archived
2026-11-10T06:20:01.109Z
SHA-256 of the archived text
ad982642080fd1588bf3b161865f9396748d12fba7a191cdc21c85a1eeb14f88
Stable URL of this page
https://metraipolis.com/documento/dc_a3bb1571b4fb

How to cite

Glycocalyx-targeted therapy prevents age-related muscle loss and declines in maximal exercise capacity — Europe PMC PMID:40892009 — Europe PMC (en), https://europepmc.org/article/MED/40892009 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a3bb1571b4fb (Metraipolis archive dc_a3bb1571b4fb, sha256 ad982642080fd1588bf3b161865f9396748d12fba7a191cdc21c85a1eeb14f88)
BibTeX
@misc{dca3bb1571b4fb,
  title = {Glycocalyx-targeted therapy prevents age-related muscle loss and declines in maximal exercise capacity — Europe PMC PMID:40892009},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40892009},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a3bb1571b4fb; sha256 ad982642080fd1588bf3b161865f9396748d12fba7a191cdc21c85a1eeb14f88},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40892009. Agents can read the archived copy with the MCP tool read_document.